Authors
Fedyk O.V., Miminoshvili L.G., Shevchenko Yu.L.
Pirogov National Medical and Surgical Center, Moscow
Abstract
Background: Infectious complications in cardiac surgery remain a leading cause of in-hospital mortality. Traditional inflammatory markers, such as absolute white blood cell (WBC) count, C-reactive protein (CRP) level, and procalcitonin (PCT), often lose their specificity against the background of systemic inflammatory response syndrome (SIRS), which inevitably occurs after major surgical trauma. This creates a dangerous “diagnostic illusion” that complicates the timely detection of sepsis.
Materials and Methods: We present a clinical case of a 70-year-old patient with high surgical risk and a burdened comorbid background (coronary artery disease, post-infarction cardiosclerosis, chronic heart failure) who underwent off-pump coronary artery bypass grafting (OPCAB). We analyzed the kinetics of routine markers (leukocytes, procalcitonin) and non-standard biomarkers – interleukin-6 (IL-6), monocyte distribution width (MDW), and monocytic human leukocyte antigen-DR expression (mHLA-DR) – in the early postoperative period amid the development of a suppurating retrosternal hematoma and severe septic shock.
Results: In the first three days postoperatively, traditional biomarkers (procalcitonin and leukocytes) demonstrated a misleading downward trend (PCT level decreased from 1.44 to 0.88 ng/mL), masking the development of a compartmentalized infection. At the same time, non-standard markers signaled an infectious threat: IL-6 demonstrated exponential growth up to 174.4 pg/mL by the third day, and the MDW parameter exceeded the critical threshold (>20.5 units). Concurrently with hyperactivation, a catastrophic drop in mHLA-DR expression was observed, from an initial 97.4% to 65% on the third day, and down to 1.0% at the onset of shock, indicating a terminal stage of immunoparalysis. This divergence of markers preceded an abrupt decompensation, the development of septic shock on the 13th day, and the subsequent addition of a fungal superinfection (Aspergillus niger, Candida albicans).
Conclusion: The integrative use of a multimarker panel, including ultra-early triggers of inflammation (IL-6), biophysical indicators of innate immune cell activation (MDW), and markers of adaptive immune functional competence (mHLA-DR), makes it possible to overcome the limitations of routine laboratory tests. Monitoring these parameters ensures the detection of infection and immunoparalysis several days before clinical hemodynamic decompensation, opening a window for timely surgical debridement and targeted immunomodulatory therapy.
Keywords: septic shock, coronary artery bypass grafting, biomarkers, IL-6, MDW, mHLA-DR, immunoparalysis, sepsis.
References
1. Jerome E, McPhail MJ, Menon K. Diagnostic accuracy of procalcitonin and interleukin-6 for postoperative infection in major gastrointestinal surgery: a systematic review and meta-analysis. The Annals of The Royal College of Surgeons of England. 2022; 104(8): 561-570. doi: 10.1308/rcsann.2022.0053.
2. Muhammad YMR, Kah KT, Kok WS. Utility of procalcitonin in diagnosing early postoperative sepsis after pediatric cardiac surgery in Malaysia. Acute and Critical Care. 2025; 40(4): 567-573. doi: 10.4266/acc.005016.
3. Matthias K, Hagen B, Simone S, et al. Prognostic value of procalcitonin in patients after elective cardiac surgery: a prospective cohort study Ann Intensive Care. 2016; 6(1): 116. doi: 10.1186/s13613-016-0215-8.
4. Aurélie G-C, Bernard A, Caroline G, et al. Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS One. 2012; 7(3): e33095. doi: 10.1371/journal.pone.0033095.
5. Daniel MF, Ingrid A-R, Marta R, et al. Interleukin-6 for diagnosis of sepsis in critically ill adult patients. Cochrane Database Syst Rev. 2015; 2015(7): CD011811. doi: 10.1002/14651858.CD011811.
6. Yenifer G-M, Jorge M-L, Felipe-Carlos S-R, et al. Efficiency of IL-6 in Early Prognosis and Follow-Up in Critically Ill Patients with Septic Shock. Diseases. 2024; 12(11): 298. doi: 10.3390/diseases12110298.
7. Vipin KS, Sankara N, Shefali G, et al. Comparison of Procalcitonin, C-reactive Protein, and Interleukin-6 in the Postoperative Course After Lung Decortication Surgery: A Prospective Observational Study. Cureus. 2025; 17(10): e95022. doi: 10.7759/cureus.95022.
8. Christoph S,Yasser S, Konrad R, et al. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care. 2006; 10(5): R145. doi: 10.1186/cc5067.
9. Aouifi A, Piriou V, Bastien O, et al. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med. 2000; 28(9): 3171-6. doi: 10.1097/00003246-200009000-00008.
10. Prescott HC, Antonelli M, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026; Crit Care Med. 2026; 54(4): 725-812. doi: 10.1097/CCM.0000000000007075.
11. Vasiliki B, Evangelia-Areti R, Evangelos J. Biomarkers to guide sepsis management. Ann Intensive Care. 2025; 15: 103. doi: 10.1186/s13613-025-01524-1.
12. Sari K, Milja H, Ville P, et al. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care. 2010; 14(6): R205. doi: 10.1186/cc9327.
13. Neeraj S, Aditya J, Nalin S, et al. Monocyte Distribution Width (MDW) as an Early Investigational Marker for the Diagnosis of Sepsis in an Emergency Department of a Tertiary Care Hospital in North India. Cureus. 2022; 14(10): e30302. doi: 10.7759/ cureus.30302.
14. Validation of monocyte distribution width decisional cutoff for sepsis detection in the acute setting. Int J Lab Hematol. 2021; 43(4): O183-O185. doi: 10.1111/ijlh.13496.
15. Instruktsiya k avtomaticheskomu gematologicheskomu analizatoru Beckman Couliter DxH 800 [Operating instructions for the Beckman Coulter DxH 900 IFU (C12557AD), 2024 automatic hydraulic unit; 2024. (In Russ.)
16. Abdullah Ö, Sercan T, Hüseyin D, et al. The Role of Monocyte Distribution Width in the Early Prediction of Sepsis in Patients Undergoing Cardiovascular Surgery: A Cross-Sectional Study. Medicina (Kaunas). 2024; 60(9): 1558. doi: 10.3390/medicina60091558.
17. Gregory JE, Quinn H, Elliott DC, et al. Diagnostic Performance of Monocyte Distribution Width for the Detection of Sepsis: A Systematic Review and Meta-Analysis. J Am Coll Emerg Physicians Open. 2025; 6(2): 100073. doi: 10.1016/j.acepjo.2025.100073.
18. Ila J, Walter PC, Edwin PR. Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis. Front Immunol. 2023; 14: 1130214. doi: 10.3389/fimmu.2023.1130214.
19. Sandra T, Jessica K, Thorsten B, et al. Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses-A Proof-of-Principle Study. Front Immunol. 2019; 10: 432. doi: 10.3389/fimmu.2019.00432.
20. Aurélie C, Bernard F, Bernard A, et al. Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care. 2010; 14(6): R208. doi: 10.1186/cc9331.
21. Guillaume M, Thomas L, Morgane G, et al. Monocyte HLA-DR expression in septic shock patients: insights from a 20-year real-world cohort of 1023 cases. Intensive Care Med. 2025; 51(10): 1820-1832. doi: 10.1007/s00134-025-08110-w.
22. Ciaccio АМ, Agnell L, Bruna L, et al. Monocyte Distribution Width (MDW) as a biomarker of sepsis: An evidenced-based laboratory medicine approach. Clin Chim Acta. 2023; 540: 117214. doi: 10.1016/j.cca.2022.117214.


